TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T38338	Voltage-gated calcium channel alpha Cav2.2	D00BPA	Olomoucine	Terminated	4592	C15H18N6O	298.34	CN1C=NC2=C(N=C(N=C21)NCCO)NCC3=CC=CC=C3	EC50 > 1000000 nM	Non binder
T38338	Voltage-gated calcium channel alpha Cav2.2	B1X9YS	8-Bromo-5H-indolo[3,2-c]quinolin-6(11H)-one	Investigative	71457749	C15H9BrN2O	313.15	C1=CC=C2C(=C1)C3=C(C4=C(N3)C=CC(=C4)Br)C(=O)N2	EC50 > 1000000 nM	Non binder
T38338	Voltage-gated calcium channel alpha Cav2.2	B2HD7Q	6-Benzylamino-2-(2-hydroxyethylamino)-7-methylpurine	Investigative	512292	C15H18N6O	298.34	CN1C=NC2=C1C(=NC(=N2)NCCO)NCC3=CC=CC=C3	EC50 > 1000000 nM	Non binder
T38338	Voltage-gated calcium channel alpha Cav2.2	B2VJ4I	(2R)-2-[[6-(Dibenzylamino)-9-propan-2-ylpurin-2-yl]amino]butan-1-ol	Investigative	71454199	C26H32N6O	444.6	CC[C@H](CO)NC1=NC2=C(C(=N1)N(CC3=CC=CC=C3)CC4=CC=CC=C4)N=CN2C(C)C	EC50 > 1000000 nM	Non binder
T38338	Voltage-gated calcium channel alpha Cav2.2	B3I1VX	Chembl4224809	Investigative	145969191	C25H24F3N3O5S	535.5	C1=CC(=CC=C1CNC2=NC3=C(S2)C=C(C=C3)OC4=CC=C(C=C4)O)OCCCN.C(=O)(C(F)(F)F)O	IC50 = 205000 nM	Non binder
T38338	Voltage-gated calcium channel alpha Cav2.2	B3JXW8	N9-Isopropyl-olomoucine	Investigative	6610355	C17H22N6O	326.4	CC(C)N1C=NC2=C(N=C(N=C21)NCCO)NCC3=CC=CC=C3	EC50 > 1000000 nM	Non binder
T38338	Voltage-gated calcium channel alpha Cav2.2	B3N8EG	Dimethylamino-olomoucine	Investigative	71452436	C17H23N7	325.4	CN1C=NC2=C(N=C(N=C21)NCCN(C)C)NCC3=CC=CC=C3	EC50 > 1000000 nM	Non binder
T38338	Voltage-gated calcium channel alpha Cav2.2	B4R8YH	Chembl4228834	Investigative	145988617	C25H24F3N3O4S	519.5	C1=CC=C(C=C1)OC2=CC3=C(C=C2)N=C(S3)NCC4=CC=C(C=C4)OCCCN.C(=O)(C(F)(F)F)O	IC50 = 218000 nM	Non binder
T38338	Voltage-gated calcium channel alpha Cav2.2	B5HRC3	Chembl4226078	Investigative	145969924	C27H25F6N3O4S	601.6	CN(CC1=CC=C(C=C1)OCCCN)C2=NC3=C(S2)C=C(C=C3)OC4=CC=C(C=C4)C(F)(F)F.C(=O)(C(F)(F)F)O	IC50 = 283000 nM	Non binder
T38338	Voltage-gated calcium channel alpha Cav2.2	B6IVH3	Chembl4224963	Investigative	145968281	C28H27F6N5O4S	643.6	CN(CC1=CC=C(C=C1)OCCCN=C(N)N)C2=NC3=C(S2)C=C(C=C3)OC4=CC=CC(=C4)C(F)(F)F.C(=O)(C(F)(F)F)O	IC50 = 202000 nM	Non binder
T38338	Voltage-gated calcium channel alpha Cav2.2	B6P9NA	(S)-Seliciclib	Investigative	6603989	C19H26N6O	354.4	CC[C@@H](CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NCC3=CC=CC=C3	EC50 = 570000 nM	Non binder
T38338	Voltage-gated calcium channel alpha Cav2.2	B8Q2YA	Chembl4226136	Investigative	145968567	C26H25F4N5O4S	579.6	C1=CC(=CC=C1CNC2=NC3=C(S2)C=C(C=C3)OC4=CC=C(C=C4)F)OCCCN=C(N)N.C(=O)(C(F)(F)F)O	IC50 = 244000 nM	Non binder
T38338	Voltage-gated calcium channel alpha Cav2.2	BDEC08	Chembl4225014	Investigative	145969886	C26H26F3N5O5S	577.6	C1=CC(=CC=C1CNC2=NC3=C(S2)C=C(C=C3)OC4=CC=C(C=C4)O)OCCCN=C(N)N.C(=O)(C(F)(F)F)O	IC50 = 253000 nM	Non binder
T38338	Voltage-gated calcium channel alpha Cav2.2	BF2JP0	Chembl4229102	Investigative	145988629	C27H25F3N6O4S	586.6	C1=CC(=CC=C1CNC2=NC3=C(S2)C=C(C=C3)OC4=CC=C(C=C4)C#N)OCCCN=C(N)N.C(=O)(C(F)(F)F)O	IC50 = 368000 nM	Non binder
T38338	Voltage-gated calcium channel alpha Cav2.2	BM1SQ6	Chembl4226327	Investigative	145969488	C27H28F3N5O5S	591.6	CN(CC1=CC=C(C=C1)OCCCN=C(N)N)C2=NC3=C(S2)C=C(C=C3)OC4=CC=C(C=C4)O.C(=O)(C(F)(F)F)O	IC50 = 432000 nM	Non binder
T38338	Voltage-gated calcium channel alpha Cav2.2	BSTI37	Aftin-4	Investigative	5289296	C20H28N6O	368.5	CC[C@H](CO)NC1=NC2=C(C(=N1)N(C)CC3=CC=CC=C3)N=CN2C(C)C	EC50 > 1000000 nM	Non binder
T38338	Voltage-gated calcium channel alpha Cav2.2	D07ADR	BOHEMINE	Investigative	2422	C18H24N6O	340.4	CC(C)N1C=NC2=C(N=C(N=C21)NCCCO)NCC3=CC=CC=C3	EC50 > 1000000 nM	Non binder
T38338	Voltage-gated calcium channel alpha Cav2.2	D0Y0ES	Indirubin-3'-monoxime	Investigative	3707	C16H11N3O2	277.28	C1=CC=C2C(=C1)C(=C(N2)O)C3=C(C4=CC=CC=C4N3)N=O	EC50 > 1000000 nM	Non binder